Cargando…

A Cost-Benefit Analysis of Lipid Standardization in the United States

INTRODUCTION: By improving lipid standardization, the Centers for Disease Control and Prevention's (CDC's) Lipid Standardization Program and Cholesterol Reference Method Laboratory Network have contributed to the marked reduction in heart disease deaths since 1980. The objective of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoerger, Thomas J., Wittenborn, John S., Young, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221577/ https://www.ncbi.nlm.nih.gov/pubmed/22005629

Ejemplares similares

Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes
por: Hoerger, Thomas J., et al.
Publicado: (2013)

The origin of cost–benefit analysis: a comparative view of France and the United States
por: Jiang, Wei, et al.
Publicado: (2021)

The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States
por: Broughel, James, et al.
Publicado: (2021)

Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes
por: Sinha, Anushua, et al.
Publicado: (2010)

Costs, Health Benefits, and Cost-Effectiveness of Chlamydia Screening and Partner Notification in the United States, 2000–2019: A Mathematical Modeling Analysis
por: Rönn, Minttu M., et al.
Publicado: (2023)

Cost-Effectiveness of Aspirin Use Among Persons With Newly Diagnosed Type 2 Diabetes
por: Li, Rui, et al.
Publicado: (2010)

Cost-benefit analysis of influenza vaccination in a public healthcare unit
por: Colombo, Giorgio L, et al.
Publicado: (2006)

Cost-Benefit Analysis of Telemedicine Systems/Units in Greek Remote Areas
por: Kouskoukis, Marios-Nikolaos, et al.
Publicado: (2016)

Cost-Effectiveness of Bariatric Surgery for Severely Obese Adults With Diabetes
por: Hoerger, Thomas J., et al.
Publicado: (2010)

Standard of care for lipedema in the United States
por: Herbst, Karen L, et al.
Publicado: (2021)

Intervention Costs From Communities Putting Prevention to Work
por: Honeycutt, Amanda A., et al.
Publicado: (2016)

An Analysis of Costs and Health Co-Benefits for a U.S. Power Plant Carbon Standard
por: Buonocore, Jonathan J., et al.
Publicado: (2016)

Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States
por: Ditkowsky, Jared, et al.
Publicado: (2017)

Cost-benefit analysis of a trifocal intraocular lens versus a monofocal intraocular lens from the patient’s perspective in the United States
por: Berdahl, John, et al.
Publicado: (2022)

Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Chen, Jieling, et al.
Publicado: (2014)

Disparities in Receipt of Eye Exams Among Medicare Part B Fee-for-Service Beneficiaries with Diabetes — United States, 2017
por: Lundeen, Elizabeth A., et al.
Publicado: (2019)

Analysis of Annual Costs of Mobile Clinics in the Southern United States
por: Attipoe-Dorcoo, Sharon, et al.
Publicado: (2020)

The Cost of Hyperkalemia in the United States
por: Betts, Keith A., et al.
Publicado: (2017)

Cost-Effectiveness of the Use of Autologous Cell Harvesting Device Compared to Standard of Care for Treatment of Severe Burns in the United States
por: Kowal, Stacey, et al.
Publicado: (2019)

Pediatric pneumonia: An analysis of cost & outcome influencers in the United States
por: Sulley, Saanie, et al.
Publicado: (2019)

Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark
por: Lee, Sei J, et al.
Publicado: (2013)

Postdelivery Intervention to Prevent Type 2 Diabetes and the Cost-Effectiveness of Screening Criteria for Gestational Diabetes
por: Neuwahl, Simon J., et al.
Publicado: (2022)

Cost-Effectiveness of Baricitinib Compared With Standard of Care: A Modeling Study in Hospitalized Patients With COVID-19 in the United States
por: Ohsfeldt, Robert, et al.
Publicado: (2021)

Risk-standardized sepsis mortality map of the United States
por: Hu, Jiun-Ruey, et al.
Publicado: (2022)

Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data
por: Danese, Mark D., et al.
Publicado: (2016)

Correction: An Analysis of Costs and Health Co-Benefits for a U.S. Power Plant Carbon Standard
por: Buonocore, Jonathan J., et al.
Publicado: (2016)

Nicotine Standards in the United States
por: Stanton, Cassandra A, et al.
Publicado: (2019)

Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates
por: Portnoy, Allison, et al.
Publicado: (2020)

Cost issues with telepsychiatry in the United States
por: Hilty, Donald M., et al.
Publicado: (2004)

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
por: Kansal, Anuraag R., et al.
Publicado: (2016)

Public Health Impact and Economic Costs of Volkswagen’s Lack of Compliance with the United States’ Emission Standards
por: Hou, Lifang, et al.
Publicado: (2016)

Cost of illness of hyponatremia in the United States
por: Boscoe, Audra, et al.
Publicado: (2006)

Congenital Chagas Disease in the United States: The Effect of Commercially Priced Benznidazole on Costs and Benefits of Maternal Screening
por: Perez-Zetune, Victoria, et al.
Publicado: (2020)

The public health benefits of insulation retrofits in existing housing in the United States
por: Levy, Jonathan I, et al.
Publicado: (2003)

Incidence and Cost of Pneumonia in Older Adults with COPD in the United States
por: Ryan, Marian, et al.
Publicado: (2013)

Direct medical costs of obesity in the United States and the most populous states
por: Cawley, John, et al.
Publicado: (2021)

Carbon benefits from protected areas in the conterminous United States
por: Zheng, Daolan, et al.
Publicado: (2013)

Cognitive benefit and cost of acute stress is differentially modulated by individual brain state
por: Kohn, Nils, et al.
Publicado: (2017)

Surgical revascularization for Moyamoya disease in the United States: A cost-effectiveness analysis
por: Wali, Arvin R., et al.
Publicado: (2021)

Assessing the Costs of Screening for Ovarian Cancer in the United States: An Evolving Analysis
por: Gorski, Justin W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lco52131eq87cvei42cejnu4j4